 |
The Journal of Neuroscience, July 12, 2006, 26(28):7405-7415; doi:10.1523/JNEUROSCI.1166-06.2006
Previous Article | Next Article 
Development/Plasticity/Repair
Combining an Autologous Peripheral Nervous System "Bridge" and Matrix Modification by Chondroitinase Allows Robust, Functional Regeneration beyond a Hemisection Lesion of the Adult Rat Spinal Cord
John D. Houle,1
Veronica J. Tom,1
Debra Mayes,2
Gail Wagoner,2
Napoleon Phillips,2 and
Jerry Silver3
1Department of Neurobiology and Anatomy, Drexel University College of Medicine, Philadelphia, Pennsylvania 19129, 2Department of Neurobiology and Developmental Sciences, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, and 3Department of Neurosciences, Case Western Reserve University, School of Medicine, Cleveland, Ohio 44106
Correspondence should be addressed to John D. Houle, Department of Neurobiology and Anatomy, Drexel University College of Medicine, 2900 Queen Lane, Philadelphia, PA 19129. Email: jhoule{at}drexelmed.edu
Chondroitinase-ABC (ChABC) was applied to a cervical level 5 (C5) dorsal quadrant aspiration cavity of the adult rat spinal cord to degrade the local accumulation of inhibitory chondroitin sulfate proteoglycans. The intent was to enhance the extension of regenerated axons from the distal end of a peripheral nerve (PN) graft back into the C5 spinal cord, having bypassed a hemisection lesion at C3. ChABC-treated rats showed (1) gradual improvement in the range of forelimb swing during locomotion, with some animals progressing to the point of raising their forelimb above the nose, (2) an enhanced ability to use the forelimb in a cylinder test, and (3) improvements in balance and weight bearing on a horizontal rope. Transection of the PN graft, which cuts through regenerated axons, greatly diminished these functional improvements. Axonal regrowth from the PN graft correlated well with the behavioral assessments. Thus, many more axons extended for much longer distances into the cord after ChABC treatment and bridge insertion compared with the control groups, in which axons regenerated into the PN graft but growth back into the spinal cord was extremely limited. These results demonstrate, for the first time, that modulation of extracellular matrix components after spinal cord injury promotes significant axonal regeneration beyond the distal end of a PN bridge back into the spinal cord and that regenerating axons can mediate the return of useful function of the affected limb.
Key words: spinal cord injury; regeneration; chondroitinase; neurotransplantation; extracellular matrix; plasticity
Received March 17, 2006;
revised May 1, 2006;
accepted June 2, 2006.
Correspondence should be addressed to John D. Houle, Department of Neurobiology and Anatomy, Drexel University College of Medicine, 2900 Queen Lane, Philadelphia, PA 19129. Email: jhoule{at}drexelmed.edu
This article has been cited by other articles:

|
 |

|
 |
 
Y. Shen, A. P. Tenney, S. A. Busch, K. P. Horn, F. X. Cuascut, K. Liu, Z. He, J. Silver, and J. G. Flanagan
PTP{sigma} Is a Receptor for Chondroitin Sulfate Proteoglycan, an Inhibitor of Neural Regeneration
Science,
October 23, 2009;
326(5952):
592 - 596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Busch, K. P. Horn, D. J. Silver, and J. Silver
Overcoming Macrophage-Mediated Axonal Dieback Following CNS Injury
J. Neurosci.,
August 12, 2009;
29(32):
9967 - 9976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Fawcett
Recovery from spinal cord injury: regeneration, plasticity and rehabilitation
Brain,
June 1, 2009;
132(6):
1417 - 1418.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.J. Salgado, R.A. Sousa, J.S. Fraga, J.M. Pego, B.A. Silva, J.O. Malva, N.M. Neves, R.L. Reis, and N. Sousa
Effects of Starch/ Polycaprolactone-based Blends for Spinal Cord Injury Regeneration in Neurons/Glial Cells Viability and Proliferation
Journal of Bioactive and Compatible Polymers,
May 1, 2009;
24(3):
235 - 248.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Darian-Smith
Synaptic Plasticity, Neurogenesis, and Functional Recovery after Spinal Cord Injury
Neuroscientist,
April 1, 2009;
15(2):
149 - 165.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Carter, M. L. Starkey, S. F. Akrimi, M. Davies, S. B. McMahon, and E. J. Bradbury
The Yellow Fluorescent Protein (YFP-H) Mouse Reveals Neuroprotection as a Novel Mechanism Underlying Chondroitinase ABC-Mediated Repair after Spinal Cord Injury
J. Neurosci.,
December 24, 2008;
28(52):
14107 - 14120.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Lu, J. Zheng, L. Xiong, M. Zimmermann, and J. Yang
Spinal cord injury-induced attenuation of GABAergic inhibition in spinal dorsal horn circuits is associated with down-regulation of the chloride transporter KCC2 in rat
J. Physiol.,
December 1, 2008;
586(23):
5701 - 5715.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. J. Alilain, X. Li, K. P. Horn, R. Dhingra, T. E. Dick, S. Herlitze, and J. Silver
Light-Induced Rescue of Breathing after Spinal Cord Injury
J. Neurosci.,
November 12, 2008;
28(46):
11862 - 11870.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hurtado, H. Podinin, M. Oudega, and B. Grimpe
Deoxyribozyme-mediated knockdown of xylosyltransferase-1 mRNA promotes axon growth in the adult rat spinal cord
Brain,
October 1, 2008;
131(10):
2596 - 2605.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. D. Bull, G. A. Limb, and K. R. Martin
Human Muller Stem Cell (MIO-M1) Transplantation in a Rat Model of Glaucoma: Survival, Differentiation, and Integration
Invest. Ophthalmol. Vis. Sci.,
August 1, 2008;
49(8):
3449 - 3456.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Low, M. Culbertson, F. Bradke, M. Tessier-Lavigne, and M. H. Tuszynski
Netrin-1 Is a Novel Myelin-Associated Inhibitor to Axon Growth
J. Neurosci.,
January 30, 2008;
28(5):
1099 - 1108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Laabs, H. Wang, Y. Katagiri, T. McCann, J. W. Fawcett, and H. M. Geller
Inhibiting Glycosaminoglycan Chain Polymerization Decreases the Inhibitory Activity of Astrocyte-Derived Chondroitin Sulfate Proteoglycans
J. Neurosci.,
December 26, 2007;
27(52):
14494 - 14501.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sirko, A. von Holst, A. Wizenmann, M. Gotz, and A. Faissner
Chondroitin sulfate glycosaminoglycans control proliferation, radial glia cell differentiation and neurogenesis in neural stem/progenitor cells
Development,
August 1, 2007;
134(15):
2727 - 2738.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Erschbamer, K. Pernold, and L. Olson
Inhibiting Epidermal Growth Factor Receptor Improves Structural, Locomotor, Sensory, and Bladder Recovery from Experimental Spinal Cord Injury
J. Neurosci.,
June 13, 2007;
27(24):
6428 - 6435.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. B. J. Cafferty, S.-H. Yang, P. J. Duffy, S. Li, and S. M. Strittmatter
Functional Axonal Regeneration through Astrocytic Scar Genetically Modified to Digest Chondroitin Sulfate Proteoglycans
J. Neurosci.,
February 28, 2007;
27(9):
2176 - 2185.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. W. Barritt, M. Davies, F. Marchand, R. Hartley, J. Grist, P. Yip, S. B. McMahon, and E. J. Bradbury
Chondroitinase ABC Promotes Sprouting of Intact and Injured Spinal Systems after Spinal Cord Injury.
J. Neurosci.,
October 18, 2006;
26(42):
10856 - 10867.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|